| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434598A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434575A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 07/07/2004 | EP1434567A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 07/07/2004 | EP1242404B1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 07/07/2004 | EP1235827B1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1218359B1 Piperazine compounds as tachykinins antagonists |
| 07/07/2004 | EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 07/07/2004 | EP1073435B1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 07/07/2004 | EP1073431B1 Use of nmda antagonists for treatment of irritable bowel syndrome |
| 07/07/2004 | EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/07/2004 | EP0928198B1 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 07/07/2004 | CN1511159A Nitrogen-based camptothecin derivatives |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease |
| 07/07/2004 | CN1511153A 苯并咪唑衍生物 Benzimidazole derivatives |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511053A HSA-free formulations of interferon-Beta |
| 07/07/2004 | CN1511038A Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 07/07/2004 | CN1511031A Solid pharmaceutical formulations comprising modafinil |
| 07/07/2004 | CN1510144A Establishment and use of hfg 12 prothrombin double chain RNA and oligonucleotide |
| 07/07/2004 | CN1509765A Freezed dry preparation of lecithal antibody and its producing method |
| 07/07/2004 | CN1509761A Cordyceps Eightzhen capsules |
| 07/07/2004 | CN1509759A Preparation of enhanced agastache capsules and quality control thereof |
| 07/07/2004 | CN1509755A Chinese medicine for treating hepatitis B and preparing method thereof |
| 07/07/2004 | CN1509754A Chinese medicine for treating hepatopathy |
| 07/07/2004 | CN1509748A Aloes extractive and use in preparation for treating astriction |
| 07/07/2004 | CN1509747A Chinese medicine for treating chronic gastritis and preparation thereof |
| 07/07/2004 | CN1509745A Preparation of wutian liver caring liquid |
| 07/07/2004 | CN1509736A Specific medicinal composition for treating hepatitis B |
| 07/07/2004 | CN1509734A Specific odontia health-care medicine |
| 07/07/2004 | CN1509733A Compound Qingdai agent for inflammatory intestinal diseases |
| 07/07/2004 | CN1509727A Rose donkey-hide gelatin and its preparation |
| 07/07/2004 | CN1509722A Cordyceps sinensis polysaccharide emulsion and preparing method thereof |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156477C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 07/07/2004 | CN1156471C 5-phridyl-1,3-azole compounds, process for producing the same and use thereof |
| 07/07/2004 | CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156308C Multi-enzyme complex capsule |
| 07/07/2004 | CN1156304C Medicine for external application for curing diseases of digestive tract, repersussion and stopping pain and its preparation method |
| 07/07/2004 | CN1156297C Medicine for treating hepatitis B |
| 07/07/2004 | CN1156292C Medicine for curing cholecystitis and its preparing method |
| 07/07/2004 | CN1156291C Mihaigao made of honey and its preparation |
| 07/07/2004 | CN1156284C Chinese Medicine for treating hepatism |
| 07/07/2004 | CN1156283C Composition for treating gastropathy |
| 07/07/2004 | CN1156280C Application of dimethyl silicone oil for treating ulcer colonitis |
| 07/07/2004 | CN1156268C Health care gargle and its preparation |
| 07/07/2004 | CN1156267C Oral Desensitizing paste and its preparing process |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759530 IBD-associated microbial nucleic acid molecules |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759421 Indoline compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759413 Use of cox-2 inhibitors as gastroprokinetics |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |
| 07/06/2004 | US6758840 Drug delivery device |
| 07/01/2004 | WO2004055051A1 Transcription control factor zhx3 |
| 07/01/2004 | WO2004055001A2 Rabeprazole calcium |
| 07/01/2004 | WO2004054984A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
| 07/01/2004 | WO2004054971A1 Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers |
| 07/01/2004 | WO2004054616A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 07/01/2004 | WO2004054600A1 Pharmaceutical compound containing silymarin and carbopol®, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 07/01/2004 | WO2004054577A1 Alpha-2-delta ligands to treat ocd and related diseases |
| 07/01/2004 | WO2004054566A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
| 07/01/2004 | WO2004054565A1 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 07/01/2004 | WO2004054563A1 Alpha-2-delta ligand for the treatment of sexual dysfunction |
| 07/01/2004 | WO2004054559A1 Alpha2delta ligands for different pharmaceutical uses |
| 07/01/2004 | WO2004054552A1 Transdermal composition of an antivomiting agent |
| 07/01/2004 | WO2004054390A1 Methods of using a beverage composition |
| 07/01/2004 | WO2004030763A3 Nonwoven loop material and process and products relating thereto |
| 07/01/2004 | WO2004014310A3 Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto |
| 07/01/2004 | WO2004002420A3 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | WO2003072048A3 Symptomatic relief of gastrointestinal disorders |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | WO2002015846A3 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 07/01/2004 | US20040127712 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127569 involving an overproduction of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) by administering to the subject an anti-inflammatory effective amount of an inducible nitric oxide synthase selective inhibitor |
| 07/01/2004 | US20040127567 cystic fibrosis; or a chronic inflammatory disorder, e.g., ulcerative colitis, Crohn's disease, chronic pancreatitis, asthma, rheumatoid arthritis or chronic gastritis; abrogated fetal lung surfactant biosynthesis |
| 07/01/2004 | US20040127546 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 07/01/2004 | US20040127544 Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127542 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 07/01/2004 | US20040127537 Stable liquid parenteral parecoxib formulation |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |